Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.03Price to Sales
VS
Market
Sector
Industry
History
$ 2.13Close
$ 1.86 - $ 7.1 52-Week Range
Ticker Information
Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINMED PHARMACEUTICALS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INM - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 5.1M | 1.03 | $ 4.94M |
| 3/31/2025 | $ 2.75M | 0.56 | $ 4.92M |
| 12/31/2024 | $ 3.86M | 0.8 | $ 4.83M |
| 9/30/2024 | $ 3.65M | 0.74 | $ 4.96M |
| 6/30/2024 | $ 3.16M | 0.69 | $ 4.6M |
| 3/31/2024 | $ 2.23M | 0.4 | $ 5.63M |
| 12/31/2023 | $ 2.16M | 0.39 | $ 5.49M |
| 9/30/2023 | $ 2.03M | 0.43 | $ 4.72M |
| 6/30/2023 | $ 2.33M | 0.56 | $ 4.14M |
| 3/31/2023 | $ 3.86M | 1.65 | $ 2.34M |
Key Performance Insights, Last 5 Years
- INMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, INMED PHARMACEUTICALS INC's average P/S has been 6.6.
- The median P/S for INMED PHARMACEUTICALS INC during this period was 0.8
- INMED PHARMACEUTICALS INC reached its highest P/S over the past 5 years at 60.79.
- The lowest P/S recorded by INMED PHARMACEUTICALS INC in the same timeframe 0.39
INMED PHARMACEUTICALS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for INMED PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 20.83M ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] INM - Price to Sales, Last 5 years
0.39
Minimum
Dec 31, 2023
60.79
Maximum
Dec 31, 2021
6.6
Average
0.8
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |